Anisoylated Plasminogen Streptokinase Activator Complex versus Placebo
- 1 January 1987
- journal article
- clinical trial
- Published by Springer Nature in Drugs
- Vol. 33 (3) , 261-267
- https://doi.org/10.2165/00003495-198700333-00048
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The Effect of Thrombolytic Therapy with Anisoylated Plasminogen Streptokinase Activator Complex on the Indicators of Myocardial SalvageDrugs, 1987
- Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.BMJ, 1986
- Clinical effects and kinetic properties of intravenous APSAC — anisoylated plasminogen-streptokinase activator complex (BRL 26921) in acute myocardial infarctionInternational Journal of Cardiology, 1986
- Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).1986
- IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1985
- Intravenous administration of a thrombolytic agent is the only realistic therapeutic approach in evolving myocardial infarctionEuropean Heart Journal, 1985
- Prevention of Myocardial Infarction by Very Early Treatment with Intracoronary StreptokinaseNew England Journal of Medicine, 1984
- Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial InfarctionNew England Journal of Medicine, 1983
- Intravenous short-term infusion of streptokinase in acute myocardial infarction.Circulation, 1983
- Revascularization after 3 hours of coronary arterial occlusion: Effects on regional cardiac metabolic function and infarct sizeThe American Journal of Cardiology, 1975